TENYCIA SHEPHERD: Open Payments
NPI 1083704704 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 10 payments from 4 companies in 2025. Trend: 2023 $14 · 2024 $36 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $114 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: ARISTADA, COBENFY, ABILIFY MAINTENA, UZEDY, LYBALVI, VIVITROL.
Industry payments across NE — which companies pay providers there.
